Industry Focus

What you should know about Juno Therapeutics' recent cancer trial stop and restart. Also, we help you prep for biopharma's second quarter earnings deluge.

Direct download: 07202016_IF_.mp3
Category:Podcast -- posted at: 12:00pm EDT

1